CiteFacts · FDA Drug Shortages · FDA source
Rifapentine Tablet, Film Coated
Status
FDA source rows are resolved or no longer current.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24) | Not stated | 08/06/2026 |
Source facts
Grouped generic ingredient: Rifapentine Tablet, Film Coated · 1 package records · Latest FDA row update: 08/06/2026
Therapeutic categories: Anti-Infective
Dosage forms: Tablet
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.